欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4562/001
药品名称Doxorubicin 2 mg/ml Concentrate for Solution for Infusion
活性成分
    • Doxorubicin hydrochloride 2.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV Utrecht The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 20075/0109 - 0024
    • Germany (DE)
      Doxorubicin Accord 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
    • Belgium (BE)
    • Ireland (IE)
    • Austria (AT)
      Doxorubicin Accord 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Lithuania (LT)
      Doxorubicin Accord 2mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      DOXORUBICIN ACCORD 2 MG/ML
    • Hungary (HU)
      DOXORUBICIN ACCORD 2 mg/ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Doxorubicin Accord
    • Romania (RO)
      Doxorubicină Accord 2 mg/ml concentrat pentru soluţie perfuzabilă
    • Slovenia (SI)
      Doxorubicin 2 mg/ml Concentrate for Solution for Infusion
    • Latvia (LV)
许可日期2010/02/24
最近更新日期2025/05/26
药物ATC编码
    • L01DB01 doxorubicin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase